VEON Q2 Sales $916.00M Down From $957.00M YoY; EBITDA $415M Down 10.6% YoY
Portfolio Pulse from Benzinga Newsdesk
VEON reported Q2 sales of $916.00 million, a decrease of 4.28% from $957.00 million in the same period last year. EBITDA also fell by 10.6% YoY.
August 04, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
VEON's Q2 sales and EBITDA have decreased YoY, indicating a potential negative impact on the company's stock price.
VEON's reported decrease in sales and EBITDA for Q2 could be a negative signal to investors, potentially leading to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100